Andrew Jackson - Chief Financial Officer at Ernexa Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
ERNA, ERNAW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Jackson since 26 Feb 2025

Holdings reported by Andrew Jackson for Ernexa Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 664,800 03 Jun 2022 Direct Common Stock, par value $0.005 per share

Transactions reported by Andrew Jackson for Ernexa Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.